Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

EAST BATON ROUGE MEDICAL CENTER LLC

NPI: 1053360651 · BATON ROUGE, LA 70816 · General Acute Care Hospital · NPI assigned 05/09/2006

$48.28M
Total Medicaid Paid
1,452,343
Total Claims
1,254,390
Beneficiaries
288
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialPOSECAI, SCOTT (CHIEF FINANCIAL OFFICER)
NPI Enumeration Date05/09/2006

Related Entities

Other providers sharing the same authorized official: POSECAI, SCOTT

ProviderCityStateTotal Paid
OCHSNER MEDICAL CENTER - NORTHSHORE, L.L.C. SLIDELL LA $6.70M
OCHSNER CLINIC LLC NEW ORLEANS LA $73K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 96,787 $3.16M
2019 128,525 $4.13M
2020 127,559 $3.71M
2021 243,559 $8.29M
2022 312,331 $10.61M
2023 321,504 $10.32M
2024 222,078 $8.06M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99284 Emergency department visit for the evaluation and management, high severity 68,971 63,618 $11.54M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 36,121 32,954 $6.38M
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 177,443 158,070 $6.10M
99283 Emergency department visit for the evaluation and management, moderate severity 53,914 50,447 $5.66M
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 68,895 58,584 $2.05M
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 28,580 26,108 $1.09M
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 19,007 17,365 $991K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 14,468 13,100 $884K
80053 Comprehensive metabolic panel 97,770 84,341 $664K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 18,329 16,359 $543K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 105,933 91,198 $542K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 24,926 20,672 $540K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 18,421 16,356 $536K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 39,439 35,778 $470K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 22,256 19,620 $414K
99282 Emergency department visit for the evaluation and management, low to moderate severity 5,441 4,986 $395K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 2,184 2,066 $392K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 15,751 4,157 $389K
71045 Radiologic examination, chest; single view 21,955 19,972 $349K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 7,570 6,846 $347K
76819 Fetal biophysical profile; without non-stress testing 8,165 5,856 $299K
81514 2,457 2,057 $281K
96375 Therapeutic injection; each additional sequential IV push 16,554 13,138 $276K
74176 Computed tomography, abdomen and pelvis; without contrast material 1,801 1,626 $274K
70450 Computed tomography, head or brain; without contrast material 3,381 3,059 $245K
36415 Collection of venous blood by venipuncture 115,559 97,094 $244K
59025 Fetal non-stress test 2,714 2,253 $229K
99215 Prolong outpt/office vis 4,396 4,087 $229K
96361 Intravenous infusion, hydration; each additional hour 18,130 13,633 $229K
83880 10,061 9,180 $228K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up 6,950 6,337 $223K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 19,051 16,055 $199K
80074 5,843 5,164 $189K
81025 29,272 26,532 $184K
87481 2,818 2,444 $170K
84484 22,429 17,773 $165K
93303 Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study 1,039 927 $164K
86803 14,796 13,220 $158K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 6,840 5,503 $156K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 5,050 1,724 $148K
80050 General health panel 3,464 3,059 $127K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 6,021 5,448 $124K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes 199 192 $122K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 2,636 2,439 $119K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation 2,150 2,031 $116K
80061 Lipid panel 11,917 10,654 $110K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring 493 309 $110K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 2,667 2,170 $109K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 3,786 2,851 $103K
86703 9,538 8,760 $96K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 1,629 957 $94K
71046 Radiologic examination, chest; 2 views 4,421 4,110 $90K
G0378 Hospital observation service, per hour 640 305 $86K
83036 Hemoglobin; glycosylated (A1C) 12,613 11,252 $83K
93320 1,047 927 $80K
74177 Computed tomography, abdomen and pelvis; with contrast material 398 343 $79K
93325 1,065 948 $74K
81000 26,871 24,113 $72K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 1,946 1,740 $72K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 310 266 $71K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 2,684 2,445 $68K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 2,369 2,169 $67K
83690 12,937 11,660 $63K
76801 1,192 1,097 $60K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 2,028 1,833 $59K
84443 Thyroid stimulating hormone (TSH) 4,846 4,225 $58K
J1050 Injection, medroxyprogesterone acetate, 1 mg 1,308 1,199 $58K
95819 530 503 $55K
86003 1,016 466 $51K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 687 586 $47K
86592 11,755 10,564 $42K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 1,171 1,127 $41K
0001A 1,145 1,127 $36K
87086 Culture, bacterial; quantitative colony count, urine 5,283 4,677 $34K
81003 20,902 18,659 $34K
J3490 Unclassified drugs 3,042 2,237 $33K
97530 Therapeutic activities, direct patient contact, each 15 minutes 1,231 482 $29K
0002A 872 819 $28K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia 104 76 $25K
87480 1,263 1,109 $24K
87660 1,263 1,109 $24K
87510 1,263 1,109 $24K
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes 876 732 $24K
84439 3,469 2,813 $23K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 728 679 $23K
82728 2,578 2,326 $22K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1,026 749 $22K
74018 841 714 $20K
87634 316 287 $20K
76830 Ultrasound, transvaginal 489 460 $19K
87081 2,905 2,678 $19K
73630 951 843 $18K
84466 2,319 2,106 $17K
19318 25 25 $17K
99281 Emergency department visit for the evaluation and management, self-limited or minor 228 219 $16K
84481 1,794 1,426 $16K
86762 1,318 1,146 $15K
J2405 Injection, ondansetron hydrochloride, per 1 mg 11,948 10,439 $15K
83516 1,539 473 $14K
J1756 Injection, iron sucrose, 1 mg 304 92 $14K
92134 810 715 $14K
45380 Colonoscopy, flexible; with biopsy, single or multiple 42 37 $13K
84702 958 799 $12K
90715 770 686 $11K
80197 1,306 752 $11K
76770 227 212 $11K
20610 179 134 $11K
73564 460 417 $10K
86140 3,260 2,926 $10K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 659 625 $9K
64721 35 30 $9K
86850 1,692 1,468 $9K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 475 373 $9K
95004 Percutaneous tests with allergenic extracts, immediate type reaction 31 31 $9K
77067 Screening mammography, bilateral, including computer-aided detection 212 202 $9K
J1885 Injection, ketorolac tromethamine, per 15 mg 5,259 4,747 $9K
83540 2,339 2,119 $9K
87340 871 794 $8K
51798 158 122 $8K
96367 467 266 $7K
87400 1,028 511 $7K
82550 1,801 1,656 $7K
83655 590 557 $7K
62323 24 24 $7K
31575 13 13 $6K
86593 1,575 1,373 $6K
J2469 Injection, palonosetron hcl, 25 mcg 159 96 $6K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 97 96 $6K
64483 46 40 $5K
J2270 Injection, morphine sulfate, up to 10 mg 3,930 3,421 $5K
95816 41 39 $5K
20611 16 13 $5K
83021 297 271 $5K
87653 129 125 $4K
82962 1,947 1,738 $4K
86900 1,678 1,456 $4K
86901 1,732 1,455 $4K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) 15 12 $4K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 117 106 $4K
J1030 Injection, methylprednisolone acetate, 40 mg 842 772 $4K
85610 1,674 1,429 $4K
80055 198 174 $4K
74019 157 143 $4K
93017 91 86 $4K
83735 868 752 $4K
90686 601 537 $4K
82950 787 739 $4K
85027 699 642 $4K
73030 179 163 $4K
83020 327 273 $3K
93296 683 586 $3K
73130 194 176 $3K
86300 181 171 $3K
80048 Basic metabolic panel (calcium, ionized) 481 428 $3K
82378 205 194 $3K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 206 95 $3K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) 23 13 $3K
83605 449 378 $3K
76705 Ultrasound, abdominal, real time with image documentation; limited 127 115 $3K
82570 827 745 $3K
95806 28 26 $3K
77336 61 24 $3K
J7120 Ringers lactate infusion, up to 1000 cc 5,251 4,298 $3K
87210 574 492 $3K
83615 791 697 $3K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 131 110 $3K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 65 62 $2K
96376 198 132 $2K
86696 143 132 $2K
85652 1,647 1,484 $2K
96417 173 107 $2K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 11,337 8,071 $2K
J3010 Injection, fentanyl citrate, 0.1 mg 4,040 3,459 $2K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units 2,411 1,480 $2K
94761 258 210 $2K
82043 404 381 $2K
82784 294 225 $2K
83993 121 110 $2K
77063 Screening digital breast tomosynthesis, bilateral 198 190 $2K
76820 56 40 $2K
J7030 Infusion, normal saline solution , 1000 cc 1,500 1,342 $2K
72082 26 26 $2K
97802 168 156 $2K
80076 234 220 $2K
86364 348 136 $2K
82607 180 151 $2K
86769 100 31 $2K
86695 143 132 $2K
97803 259 244 $2K
88305 Level IV - Surgical pathology, gross and microscopic examination 1,976 1,194 $2K
72100 61 55 $2K
85018 659 626 $2K
J2250 Injection, midazolam hydrochloride, per 1 mg 3,767 3,146 $2K
97161 28 27 $2K
92567 151 131 $2K
73562 69 64 $1K
80069 381 346 $1K
96415 60 37 $1K
82785 113 96 $1K
99152 347 275 $1K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 729 578 $1K
85730 357 308 $1K
83525 116 103 $1K
0031A 76 65 $1K
94010 39 39 $1K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 13 13 $1K
90661 169 160 $1K
82542 61 42 $1K
80179 86 85 $995.68
11721 215 183 $982.83
80177 87 83 $979.71
80320 87 66 $971.12
81002 364 317 $922.87
94060 24 24 $916.90
85651 390 351 $906.81
82105 106 94 $882.14
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 235 214 $879.37
85660 191 158 $832.01
83970 40 36 $795.50
90834 Psychotherapy, 45 minutes with patient 64 40 $781.34
82746 88 80 $748.58
84156 394 353 $714.25
J1010 Injection, methylprednisolone acetate, 1 mg 202 164 $688.58
27096 15 13 $683.86
87040 104 53 $635.90
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 945 808 $616.40
36000 36 25 $579.82
87807 48 42 $544.51
87522 Neg quan hep c or qual rna 17 13 $521.39
86160 78 39 $482.40
73610 27 25 $478.55
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 20 15 $455.08
69210 14 13 $453.45
J0696 Injection, ceftriaxone sodium, per 250 mg 99 92 $428.90
82150 75 67 $381.48
99415 Prolong outpt/office vis 554 302 $372.61
90656 90 77 $370.91
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 188 124 $319.75
76815 Ultrasound, pregnant uterus, real time with image documentation, limited 27 27 $318.64
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 26 12 $316.36
96161 35 31 $302.44
95886 25 24 $301.26
85379 49 40 $299.79
93880 14 13 $293.89
84100 98 74 $269.76
81001 62 61 $263.64
82948 134 112 $250.07
J1200 Injection, diphenhydramine hcl, up to 50 mg 324 221 $244.56
84146 15 12 $236.05
86225 32 26 $231.90
83001 20 14 $226.12
84153 17 13 $223.63
85045 103 94 $202.10
94729 31 26 $193.76
86038 25 24 $178.00
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml 1,644 1,436 $175.54
J2704 Injection, propofol, 10 mg 4,017 3,319 $155.03
J2550 Injection, promethazine hcl, up to 50 mg 169 146 $147.89
86706 29 25 $146.22
J1170 Injection, hydromorphone, up to 4 mg 84 77 $140.24
A9585 Injection, gadobutrol, 0.1 ml 29 27 $135.38
99416 Prolong outpt/office vis 210 143 $130.10
J1040 Injection, methylprednisolone acetate, 80 mg 29 27 $128.96
87338 17 17 $111.62
84480 16 14 $110.97
87088 15 13 $106.77
83010 14 13 $104.68
96127 37 31 $104.66
0352U 21 17 $86.73
82977 19 12 $80.34
87147 16 12 $60.93
J7050 Infusion, normal saline solution, 250 cc 41 24 $59.82
Q0111 Wet mounts, including preparations of vaginal, cervical or skin specimens 57 49 $55.07
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg 15 13 $38.74
J0690 Injection, cefazolin sodium, 500 mg 247 199 $35.89
90480 16 13 $28.13
94726 12 12 $25.90
J2003 Injection, lidocaine hydrochloride, 1 mg 14 12 $1.99
00813 57 55 $0.00
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 35 28 $0.00
82657 13 13 $0.00
91303 65 64 $0.00
00126 14 12 $0.00
99490 Ccm add 20min 628 626 $0.00
91300 1,876 1,674 $0.00
01810 40 35 $0.00
Q0244 Injection, casirivimab and imdevimab, 1200 mg 311 268 $0.00
00402 25 25 $0.00